Fishman P - Search Results

1

Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.

Fishman P, Madi L, Bar-Yehuda S, Barer F, Del Valle L, Khalili K. Fishman P, et al. Oncogene. 2002 Jun 6;21(25):4060-4. doi: 10.1038/sj.onc.1205531. Oncogene. 2002. PMID: 12037688

2

Mononuclear cells release low molecular weight factors with anti-cancer activity: A lower level of production by cells of cancer patients.

Cohen-Aloro D, Merimsky O, Bar-Yehuda S, Klein B, Kayzer S, Fishman P. Cohen-Aloro D, et al. Among authors: fishman p. Int J Oncol. 1998 Apr;12(4):921-5. doi: 10.3892/ijo.12.4.921. Int J Oncol. 1998. PMID: 9499456

3

Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth.

Fishman P, Bar-Yehuda S, Vagman L. Fishman P, et al. Cancer Res. 1998 Jul 15;58(14):3181-7. Cancer Res. 1998. PMID: 9679987

4

Oral administration of muscle derived small molecules inhibits tumor spread while promoting normal cell growth in mice.

Bar-Yehuda S, Farbstein T, Barer F, Ohana G, Fishman P. Bar-Yehuda S, et al. Among authors: fishman p. Clin Exp Metastasis. 1999;17(6):531-5. doi: 10.1023/a:1006649617918. Clin Exp Metastasis. 1999. PMID: 10763920

5

Adenosine acts as a chemoprotective agent by stimulating G-CSF production: a role for A1 and A3 adenosine receptors.

Fishman P, Bar-Yehuda S, Farbstein T, Barer F, Ohana G. Fishman P, et al. J Cell Physiol. 2000 Jun;183(3):393-8. doi: 10.1002/(SICI)1097-4652(200006)183:3<393::AID-JCP12>3.0.CO;2-G. J Cell Physiol. 2000. PMID: 10797314

6

Adenosine acts as an inhibitor of lymphoma cell growth: a major role for the A3 adenosine receptor.

Fishman P, Bar-Yehuda S, Ohana G, Pathak S, Wasserman L, Barer F, Multani AS. Fishman P, et al. Eur J Cancer. 2000 Jul;36(11):1452-8. doi: 10.1016/s0959-8049(00)00130-1. Eur J Cancer. 2000. PMID: 10899660

7

Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor.

Ohana G, Bar-Yehuda S, Barer F, Fishman P. Ohana G, et al. Among authors: fishman p. J Cell Physiol. 2001 Jan;186(1):19-23. doi: 10.1002/1097-4652(200101)186:1<19::AID-JCP1011>3.0.CO;2-3. J Cell Physiol. 2001. PMID: 11147810 Review.

8

Resistance of muscle to tumor metastases: a role for a3 adenosine receptor agonists.

Bar-Yehuda S, Barer F, Volfsson L, Fishman P. Bar-Yehuda S, et al. Among authors: fishman p. Neoplasia. 2001 Mar-Apr;3(2):125-31. doi: 10.1038/sj.neo.7900138. Neoplasia. 2001. PMID: 11420748 Free PMC article.

9

The A3 adenosine receptor as a new target for cancer therapy and chemoprotection.

Fishman P, Bar-Yehuda S, Barer F, Madi L, Multani AS, Pathak S. Fishman P, et al. Exp Cell Res. 2001 Oct 1;269(2):230-6. doi: 10.1006/excr.2001.5327. Exp Cell Res. 2001. PMID: 11570815

10

A possible role for IVIg in the treatment of soft tissue sarcoma: a clinical case and an experimental model.

Merimsky O, Meller I, Inbar M, Bar-Yehuda S, Shoenfeld Y, Fishman P. Merimsky O, et al. Among authors: fishman p. Int J Oncol. 2002 Apr;20(4):839-43. Int J Oncol. 2002. PMID: 11894134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

656 results

Search Page

Filters